Cargando…
Gut microbiome in gastrointestinal cancer: a friend or foe?
The impact of the gut microbiome on host health is becoming increasingly recognized. To date, there is growing evidence that the complex characteristics of the microbial community play key roles as potential biomarkers and predictors of responses in cancer therapy. Many studies have shown that alter...
Autores principales: | Liu, Yang, Baba, Yoshifumi, Ishimoto, Takatsugu, Gu, Xi, Zhang, Jun, Nomoto, Daichi, Okadome, Kazuo, Baba, Hideo, Qiu, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274484/ https://www.ncbi.nlm.nih.gov/pubmed/35844804 http://dx.doi.org/10.7150/ijbs.69331 |
Ejemplares similares
-
Tumor immune microenvironment and immune checkpoint inhibitors in esophageal squamous cell carcinoma
por: Baba, Yoshifumi, et al.
Publicado: (2020) -
Lysyl oxidase impacts disease outcomes and correlates with global DNA hypomethylation in esophageal cancer
por: Kalikawe, Rebecca, et al.
Publicado: (2019) -
PD‐L1 and PD‐L2 expression status in relation to chemotherapy in primary and metastatic esophageal squamous cell carcinoma
por: Okadome, Kazuo, et al.
Publicado: (2021) -
The Gut Microbiome in Anorexia Nervosa: Friend or Foe?
por: Ghenciulescu, Ana, et al.
Publicado: (2021) -
Adapted systemic inflammation score as a novel prognostic marker for esophageal squamous cell carcinoma patients
por: Nomoto, Daichi, et al.
Publicado: (2021)